|
Dr Robert J. Temple, Director, Office of Medical Policy, FDA
Dr Alan Breier, Chief Medical Officer & Vice President, Medical, Eli Lilly and Company
Dr Jeremy M. Levin, Senior Vice President, External Science, Technology & Licensing, Bristol-Myers Squibb Pharmaceutical Research Institute
Dr Carole Longson, Director, Centre for Health Technology Evaluation, National Institute for Health & Clinical Excellence (NICE)
Dr Anthony Ford-Hutchinson, Executive Vice President & Franchise Head - Infectious Diseases & Vaccines, Merck Research Laboratories
Dr Steven W. Ryder, Senior Vice President & Therapeutic Area Development Group Head, Pfizer Global R&D
Dr Nader Fotouhi, Center Head, Nutley & Global Head of Discovery Technologies, Roche
Dr Paul Trennery, Senior Vice President of Safety Assessment, GlaxoSmithKline
David P. Recker, MD, FACR, FACP, Senior Vice President, Clinical Science, & Interim President, Takeda Global Research & Development Center, Inc
Stuart T. Henderson, Americas Life Sciences Pharma R&D Leader, IBM Global Business Services
P. K. Tandon, PhD, Senior Vice President, Global BioMedical Operations, Genzyme Inc
Scott Mahoney, Director, PRTM Management Consultants
Dr Richard J. Heaslip, Vice President, Project & Portfolio Management, Wyeth Research
Annette Grimaldi, Managing Director, Head of Life Sciences Investment Banking, Jefferies & Company, Inc
Dr Alan Sachs, Vice President, RNA Therapeutics, Merck Research Laboratories
Dr Johan Luthman, Global Head, Therapy Area Neurology, Autoimmune & Inflammatory Diseases, Merck Serono International SA
Professor Mikael Dolsten, Private Equity Partner, OrbiMed
Ellen Strahlman, MD MHSc, Vice President, Worldwide Business Development, Pfizer Inc
Dr Felix W. Frueh, Associate Director for Genomics, Office of Clinical Pharmacology, CDER, FDA
Vaughn Kailian, General Partner, MPM Capital
Dr Joseph Hulihan, Vice President, Medical Affairs - CNS, Ortho-McNeil Janssen Scientific Affairs, LLC
Dr Eiry W. Roberts, Vice President, Transitional Phase Development, Eli Lilly and Company
Dr Frank Douglas, Partner, PureTech Ventures & former Executive Director of Center of Biomedical Innovation, Massachusetts of Technology
|
Dr Manfred Kansy, Head, Molecular Properties & Structure Property Correlation, F. Hoffmann-La Roche Ltd
Dr Nicholas Dracopoli, Vice President of Biomarkers & Translational Research, Johnson & Johnson
J. Carmel Egan, PhD, Vice President, Project Management, Lilly Research Labs, Eli Lilly and Company
Richard Gaynor, MD, Vice President, Cancer Research & Global Oncology Platform, Eli Lilly and Company
Mike Pegler, Director, PRTM Management Consultants
Frances Heller, Head, Strategic Alliances, Novartis Institutes for BioMedical Research
Dr Lorin Roskos, Senior Director, Pharmacokinetics & Toxicology, MedImmune, Inc
Dr Steven R. Deitcher, President & CEO, HANA Biosciences
Dr Nahed Ahmed, Vice President, Program Management & Strategic Operations, Amgen, Inc
Fred Aslan, MD, Vice President, Venrock
Dr Sandy Macrae, Vice President of Scientific Licensing, GlaxoSmithKline
Dr Ulrich Goldmann, Vice President & Global Head of Medical Affairs, Novartis Pharmaceuticals Corp
Stanley B. Watson, Vice President & Director, Kaiser Foundation Research Institute
Dr William Z. Potter, Vice President, Franchise Integrator Neuroscience, Merck Research Laboratories
Dr Wayne A. Rosenkrans, Director, External Relations, Evidence-based Medicine & Personalized Healthcare, AstraZeneca
Bill Crown, President, i3 Innovus
Ross Maclean, MD, Executive Director, Global Outcomes Research Strategy, Bristol-Myers Squibb
Dr Ari Gnanaskthy, Head, Research Operations, Health Economics & Outcomes Research, Novartis Pharmaceuticals Corp
Dr Michael Hanley, Vice President, Discovery Research, Amylin Pharmaceuticals, Inc
Salima Manji Lin, Associate Partner, IBM Global Business Services
Dr Martin Dyroff, Senior Director, Safety Assessment US, Global Safety Assessment, AstraZeneca Pharmaceuticals
John Hardin, MD, Chief Scientific Officer, Arthritis Foundation
Robert Baltera Jr, CEO, Amira Pharmaceuticals
Leonard D. Reeves, MD FAAFP, Assistant Director, Floyd Family Medicine Residency
|
